DGX Kronos AI forecast
A 30-trading-day price forecast for Quest Diagnostics Incorporated (DGX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Quest Diagnostics Incorporated at $219.53 on 2026-12-08, −9.5% from the last close of $242.56 on 2026-10-27. Eight out of ten sampled paths end between $210.50 and $223.65, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of DGX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $246.15 | $244.94 | $249.87 |
| 2026-11-10 | $251.87 | $245.34 | $258.43 |
| 2026-11-17 | $239.52 | $227.41 | $249.84 |
| 2026-11-24 | $231.36 | $214.64 | $244.09 |
| 2026-12-01 | $227.64 | $212.67 | $233.16 |
| 2026-12-08 | $219.53 | $210.50 | $223.65 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for DGX?
- Kronos AI's median forecast for DGX is $219.53 in 30 trading days, −9.5% from the last close, with a 10–90% range of $210.50 to $223.65.
- Is the DGX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- UNH — UnitedHealth Group Incorporated
- ELV — Elevance Health Inc.
- CI — The Cigna Group
- NTRA — Natera Inc.
- HUM — Humana Inc.
- ILMN — Illumina Inc.